Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.35 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.34 |
| ▸ | F2 | P00734 | 3/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5213937 | 0.95 | F2 (0.34) | MAPK14F2PRSS1PRSS2PRSS3 | |
| Trifluoroacetic Acid SCHEMBL5214692 | 0.93 | MAOA (0.35) | MAOAMAOBMAPK14F2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL8040508 | 0.90 | F2 (0.34) | F2PRSS1PRSS2PRSS3ADRA2C | |
| SCHEMBL7434072 | 0.90 | F2 (0.37) | MAOAMAOBMAPK14F2F10 | |
| Trifluoroacetic Acid SCHEMBL5210467 | 0.89 | F2 (0.37) | MAPK14F2PRSS1PRSS2PRSS3 | |
| Trifluoroacetic Acid SCHEMBL5212669 | 0.87 | RXRA (0.37) | F2PRSS1PRSS2PRSS3MRGPRX4 | |
| Trifluoroacetic Acid SCHEMBL5213198 | 0.87 | NPC1 (0.36) | MAPK14F2MRGPRX4OPRD1OPRM1 | |
| Trifluoroacetic Acid SCHEMBL5212857 | 0.86 | PTGES (0.35) | F2PRSS1PRSS2PRSS3MRGPRX4 | |
| Trifluoroacetic Acid SCHEMBL5212459 | 0.86 | RXRB (0.40) | MRGPRX4OPRD1FOLH1OPRM1 | |
| Trifluoroacetic Acid SCHEMBL4809174 | 0.85 | RXRA (0.37) | MAPK14MRGPRX4OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1240154-B1 | SERINE PROTEASE INHIBITORS | TULARIK LTD (GB) | 2007-02-28 | — | — | EP | disclosed |
| US-7157585-B2 | Serine protease inhibitors | TULARIK LIMITED (GB) | 2007-01-02 | — | — | US | disclosed |
| US-20050215587-A1 | Serine protease inhibitors | LIVELY SARAH E | 2005-09-29 | — | — | US | disclosed |
| US-6916957-B2 | Serine protease inhibitors | TULARIK LIMITED (GB) | 2005-07-12 | — | — | US | disclosed |
| US-20030018059-A1 | Serine protease inhibitors | PROTHERICS MOLECULAR DESIGN LIMITED (GB) | 2003-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215587-A1 | Serine protease inhibitors | PRSS1, TPSAB1, CMA1 | MAOA 232/4885MAOB 471/4885MAPK14 3086/4885 |
| US-20030018059-A1 | Serine protease inhibitors | TPSAB1, PRSS1, SERPINB1 | MAOA 666/4885MAOB 1036/4885MAPK14 3266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.